Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
association save search
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
BIVI | News | $0.4931 0.96% 430K
|
Health Technology
|
| O: 5.49%
H: 2.0%
C: -2.0%
ne3107
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
CMMB | News | $0.691 -1.29% 10K
|
Manufacturing
|
| O: -3.38%
H: 0.0%
C: 0.0%
ccl24 disease association publication sclerosis
UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers
Published: 2024-04-17 (Crawled : 00:00) - biospace.com/
URGN | $14.03 -1.61% 170K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
association for meeting benefits
Kroger Invites Prospective Associates to Discover a Career
Published: 2024-04-17 (Crawled : 19:00) - prnewswire.com
KR | $56.575 1.81% 2.2M
|
Retail Trade
| Email alert
Add to watchlist
Horatio Alger Association Honors Outstanding Leaders and Celebrates 40th Anniversary of Scholarship Program at the 77th Annual Horatio Alger Awards
Published: 2024-04-17 (Crawled : 16:00) - prnewswire.com
WRB | $82.22 1.53% 550K
|
Finance
|
| O: -0.18%
H: 0.0%
C: -1.54%
association awards program leaders
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
Published: 2024-04-17 (Crawled : 11:00) - globenewswire.com
CTSO | $0.809 1.0% 31K
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: 0.0%
association presentation for meeting trial results
ONE Gas to Participate in American Gas Association Financial Forum
Published: 2024-04-15 (Crawled : 21:00) - prnewswire.com
OGS | $63.63 2.15% 95K
|
Utilities
|
| O: -0.6%
H: 0.0%
C: -0.88%
MS | News 0 d | $91.34 1.2% 2.9M
|
Finance
|
| O: 2.98%
H: 0.0%
C: 0.0%
association one gas financial
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVO | $123.01 0.21% 2.6M
|
Health Technology
|
| O: 1.04%
H: 0.19%
C: -1.52%
Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care
Published: 2024-04-15 (Crawled : 14:00) - biospace.com/
OM | $2.295 2.0% 590K
|
Health Technology
|
| O: 0.0%
H: 2.93%
C: -0.49%
association care medical
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
LGVN | News P 0 d | $1.955 -2.74% 370K
|
|
| O: 41.42%
H: 42.68%
C: 22.59%
conference disease association alzheimer’s presentation international research for trial
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
ONVO | $1.13 -1.74% 150K
|
Health Technology
|
| O: 64.34%
H: 4.82%
C: -18.67%
fxr314 metabolic liver positive for results
Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
QLGN | $0.301 -3.43% 22K
|
Health Technology
|
| O: -2.03%
H: 2.35%
C: -2.76%
association direct cancer research meeting
Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
APLM | $0.47 -7.84% 150K
|
n/a
|
| O: -2.99%
H: 6.9%
C: 0.0%
association cancer research for meeting
BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
BTAI | $2.735 7.26% 400K
|
Health Technology
|
| O: 0.96%
H: 1.9%
C: 0.0%
bxcl501 alzheimer’s dementia for trial therapeutics
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
MDNAF | $1.24 67K
|
n/a
|
| O: 18.35%
H: 13.64%
C: 12.4%
mdna11 association cancer ongoing expansion research for meeting results study
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
Published: 2024-04-09 (Crawled : 21:00) - globenewswire.com
MDNAF | $1.24 67K
|
n/a
|
| O: 18.35%
H: 13.64%
C: 12.4%
mdna11 association cancer ongoing expansion research for meeting results study
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
MURA | $3.68 3.08% 120K
|
|
| O: -1.2%
H: 1.94%
C: 0.0%
il-18 association cancer research preclinical for meeting il-12
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
STTK | $9.92 -2.07% 220K
|
Health Technology
|
| O: -1.11%
H: 9.78%
C: 9.66%
association presentation cancer research preclinical for meeting
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-09 (Crawled : 16:00) - globenewswire.com
CMPX | $1.425 -4.36% 130K
|
Professional, Scientific, and T...
|
| O: 2.06%
H: 0.0%
C: 0.0%
association tumors cancer research for meeting therapeutics negative
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.